Provided by Tiger Trade Technology Pte. Ltd.

Eli Lilly

985.08
+7.830.80%
Post-market: 984.01-1.0700-0.11%19:59 EDT
Volume:1.98M
Turnover:1.96B
Market Cap:931.28B
PE:42.92
High:1,003.22
Open:980.13
Low:978.00
Close:977.25
52wk High:1,133.95
52wk Low:623.78
Shares:945.38M
Float Shares:945.00M
Volume Ratio:0.91
T/O Rate:0.21%
Dividend:6.00
Dividend Rate:0.61%
EPS(TTM):22.95
EPS(LYR):22.95
ROE:101.16%
ROA:19.42%
PB:35.10
PE(LYR):42.92

Loading ...

CMS: Drugs Selected for Third Cycle of Medicare Drug Price Negotiation Are Rexulti, Trulicity, Verzenio, Xeljanz; Xeljanz Xr and Xolair

THOMSON REUTERS
·
Jan 28

Eli Lilly & Co. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Jan 28

Eli Lilly's Jaypirca Gets Approval in Canada for Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia

MT Newswires Live
·
Jan 28

Citigroup Maintains Street-High $1,500 Price Target on Eli Lilly Stock (LLY)

TIPRANKS
·
Jan 28

Eli Lilly’s Pirtobrutinib Trial Completion Signals Next Phase in the BTK Inhibitor Race

TIPRANKS
·
Jan 28

Jaypirca® (Pirtobrutinib), the First and Only Non-Covalent (Reversible) Btk Inhibitor, NOW Available in Canada for Adult Patients With Relapsed or Refractory Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia

THOMSON REUTERS
·
Jan 27

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Pennant Group (PNTG) and Warby Parker (WRBY)

TIPRANKS
·
Jan 27

Roche's CT-388 Could Compete With Lilly's Zepbound on Obesity Efficacy -- Market Talk

Dow Jones
·
Jan 27

Roche obesity drug shows 22.5% weight loss as it seeks to catch up with Lilly, Novo

Reuters
·
Jan 27

Rothschild & Co. Redburn Adjusts PT on Eli Lilly and Co. to $830 From $775, Maintains Neutral Rating

MT Newswires Live
·
Jan 27

Eli Lilly’s (LLY) New Marketing Focuses on ‘Weight Stigma’

TIPRANKS
·
Jan 26

Truist Financial Reaffirms Their Buy Rating on Eli Lilly & Co (LLY)

TIPRANKS
·
Jan 26

Eli Lilly Advances Remternetug Delivery Options With Completed Device Study

TIPRANKS
·
Jan 24

Bernstein Sees Eli Lilly Stock (LLY) Hitting $1,300 Per Share

TIPRANKS
·
Jan 23

Eli Lilly, Novo Nordisk Set for Fierce Battle in India’s Obesity Drug Market as Sun Pharma Wins Wegovy Generic Nod

TIPRANKS
·
Jan 23

Indian drugmakers get regulatory nod to sell generic Wegovy, heating obesity‑drug race

Reuters
·
Jan 23

Eli Lilly Expands Oncology Imaging Footprint With New Phase 1 PET Tracer Study

TIPRANKS
·
Jan 23

Eli Lilly Advances Retatrutide With New Phase 3b Obesity Dosing Study

TIPRANKS
·
Jan 23

Many patients may keep off lost pounds after stopping a GLP-1, US data suggests

Reuters
·
Jan 22

Eli Lilly & Co. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jan 22